Studies related to Plasminogen Activator Inhibitor-1 and Red Clover Extract

Modest Protective Effects Of Isoflavones From A Red Clover-derived Dietary Supplement On Cardiovascular Disease Risk Factors In Perimenopausal Women, And Evidence Of An Interaction With ApoE Genotype In 49-65 Year-old Women

43.5mg of red clover isoflavones daily for one year has failed to significantly improve cardiovascular risk factors, and when controlling for the ApoE genotype there was a stronger trend for inprovement that still failed to reach statistical significance.